Clinical Trial Update: JETi Hong Kong Post Market Study (PMS)

View source ↗

Summary

Post-market study results for Abbott's JETi device in Hong Kong have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Thrombosis
• Peripheral Arteriovenous Thrombosis
• Peripheral Venous Thrombosis

Snippet

Sponsor: Abbott Medical Devices | Conditions: Peripheral Venous Thrombosis, Peripheral Arterial Thrombosis | Status: COMPLETED | Results posted: 2025-12-16